Broad-spectrum chemokine inhibition ameliorates experimental obliterative bronchiolitis
- 1 April 2003
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 75 (4) , 1118-1122
- https://doi.org/10.1016/s0003-4975(02)04758-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Role of chemokines in the pathogenesis of asthmaNature Reviews Immunology, 2001
- CXC Chemokine Redundancy Ensures Local Neutrophil Recruitment during Acute InflammationThe American Journal of Pathology, 2001
- The pan‐chemokine inhibitor NR58‐3.14.3 abolishes tumour necrosis factor‐α accumulation and leucocyte recruitment induced by lipopolysaccharide in vivoImmunology, 2001
- Neuroprotection in Ischemia–Reperfusion Injury: An Antiinflammatory Approach Using a Novel Broad-Spectrum Chemokine InhibitorJournal of Cerebral Blood Flow & Metabolism, 2001
- Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejectionJournal of Clinical Investigation, 2000
- OBLITERATIVE AIRWAY DISEASE AFTER HETEROTOPIC TRACHEAL XENOTRANSPLANTATIONTransplantation, 1997
- Cloning and Characterization of a Novel Murine β Chemokine Receptor, D6Journal of Biological Chemistry, 1997
- Obliterative bronchiolitis after lung and heart-lung transplantationThe Annals of Thoracic Surgery, 1995
- Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantationThe Annals of Thoracic Surgery, 1995
- Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTESNature, 1990